N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction

被引:24
作者
Li, Jian [1 ,2 ]
Wang, Fangjuan [3 ]
Liu, Yongkang [2 ]
Wang, Huaizhi [4 ]
Ni, Bing [1 ]
机构
[1] Third Mil Med Univ, Army Med Univ, Coll High Altitude, Dept Pathophysiol, Chongqing 400038, Peoples R China
[2] Air Force Hosp Western Theater Command, Dept Gen Surg, Chengdu 610021, Peoples R China
[3] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Cardiol, Chongqing 400038, Peoples R China
[4] Univ Chinese Acad Sci, Chongqing Gen Hosp, Inst Hepatopancreatobiliary Surg, Chongqing 401120, Peoples R China
关键词
m(6)A; Pancreatic cancer; RNA modification; clinical application; MESSENGER-RNA METHYLATION; CIRCULATING TUMOR-CELLS; BODY-MASS INDEX; METTL3; PROMOTES; UP-REGULATION; SELF-RENEWAL; NUCLEAR-RNA; YTH DOMAIN; FAT MASS; DEMETHYLASE;
D O I
10.7150/ijbs.60115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N-6-methyladenosine (m(6)A), the most abundant RNA modification in eukaryotes, plays a pivotal role in regulating many cellular and biological processes. Aberrant m(6)A modification has recently been involved in carcinogenesis in various cancers, including pancreatic cancer. Pancreatic cancer is one of the deadliest cancers. It is a heterogeneous malignant disease characterized by a plethora of diverse genetic and epigenetic events. Increasing evidence suggests that dysregulation of m(6)A regulatory factors, such as methyltransferases, demethylases, and m(6)A-binding proteins, profoundly affects the development and progression of pancreatic cancer. In addition, m(6)A regulators and m(6)A target transcripts may be promising early diagnostic and prognostic cancer biomarkers, as well as therapeutic targets. In this review, we highlight the biological functions and mechanisms of m(6)A in pancreatic cancer and discuss the potential of m(6)A modification in clinical applications.
引用
收藏
页码:2323 / 2335
页数:13
相关论文
共 125 条
[1]   HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events [J].
Alarcon, Claudio R. ;
Goodarzi, Hani ;
Lee, Hyeseung ;
Liu, Xuhang ;
Tavazoie, Saeed ;
Tavazoie, Sohail F. .
CELL, 2015, 162 (06) :1299-1308
[2]   Molecular mediators of peritoneal metastasis in pancreatic cancer [J].
Avula, Leela Rani ;
Hagerty, Brendan ;
Alewine, Christine .
CANCER AND METASTASIS REVIEWS, 2020, 39 (04) :1223-1243
[3]   WTAP is a novel oncogenic protein in acute myeloid leukemia [J].
Bansal, H. ;
Yihua, Q. ;
Iyer, S. P. ;
Ganapathy, S. ;
Proia, D. ;
Penalva, L. O. ;
Uren, P. J. ;
Suresh, U. ;
Carew, J. S. ;
Karnad, A. B. ;
Weitman, S. ;
Tomlinson, G. E. ;
Rao, M. K. ;
Kornblau, S. M. ;
Bansal, S. .
LEUKEMIA, 2014, 28 (05) :1171-1174
[4]   Role of RNA modifications in cancer [J].
Barbieri, Isaia ;
Kouzarides, Tony .
NATURE REVIEWS CANCER, 2020, 20 (06) :303-322
[5]   Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker [J].
Beharry, Andrew A. ;
Lacoste, Sandrine ;
O'Connor, Timothy R. ;
Kool, Eric T. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (11) :3647-3650
[6]   HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g [J].
Cai, Xiaoli ;
Wang, Xiao ;
Cao, Can ;
Gao, Yuen ;
Zhang, Shuqin ;
Yang, Zhe ;
Liu, Yunxia ;
Zhang, Xiaodong ;
Zhang, Weiying ;
Ye, Lihong .
CANCER LETTERS, 2018, 415 :11-19
[7]   The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells [J].
Cao, Junguo ;
Mu, Qingchun ;
Huang, Haiyan .
STEM CELLS INTERNATIONAL, 2018, 2018
[8]   YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells [J].
Chen, Jixiang ;
Sun, Yaocheng ;
Xu, Xiao ;
Wang, Dawei ;
He, Junbo ;
Zhou, Hailang ;
Lu, Ying ;
Zeng, Jian ;
Du, Fengyi ;
Gong, Aihua ;
Xu, Min .
CELL CYCLE, 2017, 16 (23) :2259-2271
[9]   High-Resolution N6-Methyladenosine (m6A) Map Using Photo-Crosslinking-Assisted m6A Sequencing [J].
Chen, Kai ;
Lu, Zhike ;
Wang, Xiao ;
Fu, Ye ;
Luo, Guan-Zheng ;
Liu, Nian ;
Han, Dali ;
Dominissini, Dan ;
Dai, Qing ;
Pan, Tao ;
He, Chuan .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (05) :1587-1590
[10]   N6-methyladenosine-induced ERR. triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming [J].
Chen, Zhuojia ;
Wu, Long ;
Zhou, Jiawang ;
Lin, Xinyao ;
Peng, Yanxi ;
Ge, Lichen ;
Chiang, Cheng-Ming ;
Huang, Hui ;
Wang, Hongsheng ;
He, Weiling .
THERANOSTICS, 2020, 10 (08) :3382-3396